Fitzgerald James T, Stanfield RB, Tang T
Therapeutic area: Nutritional and Metabolic Diseases, Endocrine System Diseases
To measure patient and provider perceptions of 18 diabetes-related concepts
Novo Nordisk (Denmark)
Therapeutic area: Nutritional and Metabolic Diseases, Endocrine System Diseases
To assess symptom experience of patients with diabetes mellitus
Hanifin J.M., Thurston M., Omoto M. et al.
Therapeutic area: Skin and Connective Tissue Diseases
To assess extention of the eczema disease at 4 body sites (Head/neck, Trunk, Upper extremities and Lower extremities) and measures 4 clinical signs : Erythema, Inuration/Papulation, Excoriation and Lichenification.
Johns Murray W, MB, BS, BSc, PhD
Therapeutic area: Nervous System Diseases, Pathological Conditions, Signs and Symptoms
To measure a subject's usual level of daytime sleepiness or average sleep propensity
Johns Murray W, MB, BS, BSc, PhD
Therapeutic area: Nervous System Diseases, Pathological Conditions, Signs and Symptoms
To measure the subject’s average level of daytime sleepiness in daily life
McCoul Edward D., Anand Vijay K., Christos Paul J.
Disease-specific instrument used for the clinical assessment of symptoms and treatment outcome in Eustachian tube dysfunction
Klassen Anne F, Cano Stefan J, Pusic Andrea L
Therapeutic area: Psychological Phenomena and Processes
To measure appearance, quality of life and experience of health care among patients undergoing any type of surgical or nonsurgical facial aesthetic treatment.
Danone (France), Mapi
Therapeutic area: Generic
To assess the perceived outcomes associated with diet/food intake in the general adult population
Drossman Douglas, Li Zhiming, Toner Brenda B et al.
Therapeutic area: Digestive System Diseases
To quantify illness severity in patients with painful functional bowel disorders
Mapi, Chassany Olivier, Parke Davis
Therapeutic area: Pathological Conditions, Signs and Symptoms, Digestive System Diseases
To measure the specific physical, psychological, and perpetual impacts of dyspepsia and irritable bowel syndrome
Bennett Robert, Burckhardt Carol, Clark Sharon
Therapeutic area: Nervous System Diseases, Musculoskeletal Diseases
To measure fibromyalgia patient status, progress and outcomes
Bennett Robert, Friend Ronald
Therapeutic area: Nervous System Diseases, Musculoskeletal Diseases
To measure fibromyalgia patient status, progress and outcomes
Perrot Serge, Bouhassira Didier
Therapeutic area: Nervous System Diseases, Musculoskeletal Diseases
Screening tool developed for the detection of fibromyalgia syndrome in patients with diffuse chronic pain
Fisk John D
Therapeutic area: Pathological Conditions, Signs and Symptoms
To assess the problems in patients’ quality of life that they attribute to their symptoms of fatigue
Genentech, Inc.
Therapeutic area: Eye Diseases
To assess reading function in patients with geographic atrophy (GA) from age-related macular degeneration (AMD)
Janssen Global Services, LLC (USA)
Therapeutic area: Digestive System Diseases, Pathological Conditions, Signs and Symptoms
To assess the severity of patient-reported gastroparesis symptoms, for use in clinical trials
Goldberg David
Therapeutic area: Psychiatry/Psychology
Screening instrument to detect psychiatric disorders in community settings and non-psychiatric clinical settings, such as primary care or general practice
Eypasch Ernst
Therapeutic area: Digestive System Diseases
To assess quality of life specific for the gastrointestinal tract
Bausch & Lomb Chauvin (France), Mapi
Therapeutic area: Eye Diseases
To evaluate the impact of pathology and its treatment on the everyday life of the patient
Lyketsos Constantine G., Galik Elizabeth, Steele Cynthia et al.
Therapeutic area: Nervous System Diseases, Mental Disorders
To assess medical comorbidity in dementia patients